![Transparency Market Researchが調査・発行した産業分析レポートです。HIV/AIDSイムノアッセイ診断の世界市場：製品別、技術別、エンドユーザー別 / HIV/AIDS Immunoassay Diagnostics Market (Product: Analyzers and Kits & Reagents; Technology: Enzyme-linked Immunosorbent Assay [ELISA], Chemiluminescence Immunoassay [CLIA], and Others [Immunofluorescent Assay {IFA}, Radioimmunoassay {RIA}, and Enzyme-linked Fluorescent Assay {ELFA}]; and End User: Hospitals, Diagnostic Laboratories, Blood Banks, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-2JN032資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-83.gif) | • レポートコード：TPM-2JN032 • 出版社/出版日：Transparency Market Research / 2019年12月30日 • レポート形態：英文、PDF、175ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートはHIV/AIDSイムノアッセイ診断の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場状況、市場動向、製品別分析、技術別分析、エンドユーザー別分析、地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、次の構成でお届けいたします。 ・序論 ・仮定・研究方法 ・エグゼクティブサマリー ・市場状況 ・市場動向 ・HIV/AIDSイムノアッセイ診断の世界市場：製品別 ・HIV/AIDSイムノアッセイ診断の世界市場：技術別 ・HIV/AIDSイムノアッセイ診断の世界市場：エンドユーザー別 ・HIV/AIDSイムノアッセイ診断の世界市場：地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ） ・HIV/AIDSイムノアッセイ診断の北米市場分析・予測 ・HIV/AIDSイムノアッセイ診断の欧州市場分析・予測 ・HIV/AIDSイムノアッセイ診断のアジア太平洋市場分析・予測 ・HIV/AIDSイムノアッセイ診断の中南米市場分析・予測 ・HIV/AIDSイムノアッセイ診断の中東・アフリカ市場分析・予測 ・競争状況 |
Diagnostic technology has evolved at a rapid pace over the past decade, owing to significant breakthroughs in research and development. Within the HIV/AIDS immunoassay diagnostics market landscape, the demand for automated clinical laboratory has paved the way for efficient and reliable antibodies and antigen identification techniques. Despite significant progress, the human immunodeficiency virus (HIV) continues to be a major global health problem and a medical challenge. Some of the most effective and critical HIV management strategies include antiretroviral therapy (ART) initiation, early diagnosis, and assessment of the viral load.
HIV diagnostic tests offer two solutions – detection of virus molecules (p24 antigen and HIV RNA) and/or different antibodies to the virus. HIV/AIDS immunoassays, in particular, are used to detect antibodies and p24 antigen. Due to the growing need to curb HIV/AIDS and other types of HIV infections, the demand for efficient diagnostic techniques has increased significantly worldwide. The global HIV/AIDS immunoassay diagnostics market is expected to expand from ~US$ 570 Mn in 2019 to a value of ~US$ 870 Mn by 2027.
Around 38 million individuals across the world had HIV in 2018 of which, approximately 36 million were adults. Furthermore, ~1.7 million new HIV cases were registered in 2018 and the numbers continue to grow, especially in the sub-Saharan region and low-income economies. Key participants involved in the HIV/AIDS immunoassay diagnostics market are focusing on simplifying and improving the effectiveness of HIV diagnostics.
Antibody screening tests including the enzyme linked immunosorbent assay (ELISA) are predominantly used to measure antibodies in blood. This test is generally the first test ordered by healthcare professionals to detect HIV antigens in the blood. Traditionally, enzyme-linked immunosorbent assays are complex, expensive, and often require a skilled professional. However, as ELISA is easier and safer than radioimmunoassay (RIA); its adoption will continue to grow at a steady pace over the forecast period (2019-2027). Thus, the ELISA segment is projected to create an incremental opportunity of ~US$ 112 Mn between the stipulated timeframe of the study. The diagnostic results using ELISA could take a few days, which has led to the need for rapid testing techniques.
Despite steady growth of the ELISA segment, the chemiluminescent immunoassay segment (CLIA) segment is expected to hold a larger share of the HIV/AIDS immunoassay diagnostics market, in terms of value. By the end of 2027, the CLIA segment is likely to account for ~48% of the total share of the HIV/AIDS immunoassay diagnostics market and witness a CAGR of ~6% during the forecast period. Over the past few years, CLIA has gained significant popularity in various sectors, including clinical diagnosis, life sciences, pharmaceutical analysis, and environmental monitoring, among others due to factors such as optimum specificity, easy-to-use equipment, wider linear range, and high sensitivity. Techniques based on chemiluminescent are increasingly being used for clinical analysis and several biomedical research activities.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global HIV/AIDS Immunoassay Diagnostics Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Technological Advancements
5.2. Key Industry Developments
5.3. Epidemiology Analysis
5.4. Number of HIV/AIDS Immunoassay Diagnostics Tests, by Region
5.5. Pricing Analysis
6. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Product
6.1. Introduction & Definition
6.2. Global HIV/AIDS Immunoassay Diagnostics Market Value Forecast, by Product, 2017–2027
6.2.1. Analyzers
6.2.2. Kits & Reagents
6.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product
7. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Technology
7.1. Introduction
7.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
7.2.1. ELISA
7.2.2. CLIA
7.2.3. Others
7.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology
8. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by End User
8.1. Introduction
8.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
8.2.1. Hospitals
8.2.2. Diagnostic Laboratories
8.2.3. Blood Banks
8.2.4. Others
8.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User
9. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Region
9.1. Introduction
9.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Region
10. North America HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast
10.1. Introduction
10.2. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
10.2.1. Analyzers
10.2.2. Kits & Reagents
10.3. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
10.3.1. ELISA
10.3.2. CLIA
10.3.3. Others
10.4. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Blood Banks
10.4.4. Others
10.5. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Technology
10.6.3. By End User
10.6.4. By Country
11. Europe HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast
11.1. Introduction
11.2. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
11.2.1. Analyzers
11.2.2. Kits & Reagents
11.3. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
11.3.1. ELISA
11.3.2. CLIA
11.3.3. Others
11.4. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Blood Banks
11.4.4. Others
11.5. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Technology
11.6.3. By End User
11.6.4. By Country/Sub-region
12. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
12.2.1. Analyzers
12.2.2. Kits & Reagents
12.3. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
12.3.1. ELISA
12.3.2. CLIA
12.3.3. Others
12.4. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Blood Banks
12.4.4. Others
12.5. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Technology
12.6.3. By End User
12.6.4. By Country/Sub-region
13. Latin America HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast
13.1. Introduction
13.2. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
13.2.1. Analyzers
13.2.2. Kits & Reagents
13.3. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
13.3.1. ELISA
13.3.2. CLIA
13.3.3. Others
13.4. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Blood Banks
13.4.4. Others
13.5. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Technology
13.6.3. By End User
13.6.4. By Country/Sub-region
14. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
14.2.1. Analyzers
14.2.2. Kits & Reagents
14.3. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
14.3.1. ELISA
14.3.2. CLIA
14.3.3. Others
14.4. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Blood Banks
14.4.4. Others
14.5. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Technology
14.6.3. By End User
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Global HIV/AIDS Immunoassay Diagnostics Market Share Analysis, by Company (2018)
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.1.1. Company Description
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. Bio-Rad Laboratories, Inc.
15.3.2.1. Company Description
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. Siemens Healthineers AG.
15.3.3.1. Company Description
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. DiaSorin S.p.A.
15.3.4.1. Company Description
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Abbott Laboratories
15.3.5.1. Company Description
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. Ortho Clinical Diagnostics (a part of Carlyle Group)
15.3.6.1. Company Description
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd.
15.3.7.1. Company Description
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. bioMérieux SA
15.3.8.1. Company Description
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
15.3.9. Fujirebio (Miraca Group)
15.3.9.1. Company Description
15.3.9.2. Business Overview
15.3.9.3. Financial Overview
15.3.9.4. Strategic Overview
15.3.9.5. SWOT Analysis
List of TablesTable 01: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 03: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 04: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 05: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 06: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 07: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 08: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 09: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 11: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 12: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 13: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 15: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 16: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 17: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 19: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 20: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 21: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 23: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 24: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017–2027